Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).
about
Interleukin-4 inhibition of interleukin-1-induced expression of matrix metalloproteinase-3 (MMP-3) is independent of lipoxygenase and PPARgamma activation in human gingival fibroblasts.Critical role of glutamic acid 202 in the enzymatic activity of stromelysin-1 (MMP-3).2D-electrophoresis and multiplex immunoassay proteomic analysis of different body fluids and cellular components reveal known and novel markers for extended fastingHuman retinal pigment epithelial lysis of extracellular matrix: functional urokinase plasminogen activator receptor, collagenase, and elastaseSurvey of the year 2000 commercial optical biosensor literature.Matrix metalloproteinase-3 (MMP3) and MMP9 genes and risk of myocardial infarction, ischemic stroke, and hemorrhagic stroke.Physiology and pathophysiology of matrix metalloproteases.Structural and functional characterization of cleavage and inactivation of human serine protease inhibitors by the bacterial SPATE protease EspPα from enterohemorrhagic E. coli.Hyperglycemia-suppressed expression of Serpine1 contributes to delayed epithelial wound healing in diabetic mouse corneas.Enhanced fibrinolysis in fingerstick blood samples: a possible role for matrix metalloproteinase-9.The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque.A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms.Interleukin-4 suppresses IL-1-induced expression of matrix metalloproteinase-3 in human gingival fibroblasts.IL-4 inhibition of IL-1 induced Matrix metalloproteinase-3 (MMP-3) expression in human fibroblasts involves decreased AP-1 activation via negative crosstalk involving of Jun N-terminal kinase (JNK).The conversion of active to latent plasminogen activator inhibitor-1 is an energetically silent event.Complex Regulation of the Pericellular Proteolytic Microenvironment during Tumor Progression and Wound Repair: Functional Interactions between the Serine Protease and Matrix Metalloproteinase Cascades.PAI-1: An Integrator of Cell Signaling and Migration.Urokinase plasminogen activator stimulates function of active forms of stromelysin and gelatinases (MMP-2 and MMP-9) in cirrhotic tissue.NF-kappaB and ZBP-89 regulate MMP-3 expression via a polymorphic site in the promoter.Involvement of matrix metalloproteinase type-3 in hepatocyte growth factor-induced invasion of human hepatocellular carcinoma cells.Inhibition of host extracellular matrix destructive enzyme production and activity by a high-molecular-weight cranberry fraction.Tumor tissue concentrations of the proteinase inhibitors tissue inhibitor of metalloproteinases-1 (TIMP-1) and plasminogen activator inhibitor type 1 (PAI-1) are complementary in determining prognosis in primary breast cancer.The anti-angiogenic activity of rPAI-1(23) inhibits fibroblast growth factor-2 functions.
P2860
Q30830094-C0896D4E-2D95-406D-9915-1C34F8EF9621Q31897979-456DDAE0-351B-4D9A-A129-E63955B8BA9BQ33856359-E509C9C9-82E7-4BFE-ABF9-F74C225737CEQ34330943-91DC5F3E-77B5-4C23-99E0-913388BA0BA3Q34464911-512E7002-EE1B-4326-9868-42BEC4C676E8Q34798470-1BD6FB04-57F9-4285-A355-2237C0E4F2FCQ35007715-833F2A38-F82B-4879-87F4-52CD4E62775EQ35367680-0AAC7A0E-F381-4ACF-BCD8-34DD72C92DDDQ35678791-8DB38A90-F7C9-4CE0-B050-3FCAB29EE8E9Q36016438-ED617231-C376-4737-9C3A-B573A2ACF3F2Q37331866-EA7DCEFC-C898-4F6F-88B9-A7981EA6798DQ38361908-C89A1934-BE49-458B-A7A7-731D205D03BDQ38504663-2ED46032-B385-439F-8BE7-9338DFC733EEQ39162312-99955EF6-C3F0-4331-9EBC-F5FB4CF91561Q40325503-4ECAB580-25C5-4684-B33E-9DD3F73F5295Q41808886-64182638-A395-4A6F-9B92-10FB5D99F61AQ41896599-7FB5B711-0DA9-4600-81A4-8D349E48E300Q42805229-C6D55C0E-31EB-4CE0-9934-A4184B687657Q43132243-17341D6D-F124-48F4-B588-B67FD036FDC9Q43844074-CB5C1AB6-D674-4555-9B0B-10A98BA40396Q47300666-8B56B0E6-3A71-4BBB-A21D-D2DDE2C3D2A2Q47996841-B32F919E-6CAC-4266-8B2B-618A6EB3950AQ54355360-92388B37-98D3-47AD-A110-504A7FE42EC3
P2860
Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
Inactivation of plasminogen ac ...... is with stromelysin-1 (MMP-3).
@en
Inactivation of plasminogen ac ...... proteolysis with stromelysin-1
@nl
type
label
Inactivation of plasminogen ac ...... is with stromelysin-1 (MMP-3).
@en
Inactivation of plasminogen ac ...... proteolysis with stromelysin-1
@nl
prefLabel
Inactivation of plasminogen ac ...... is with stromelysin-1 (MMP-3).
@en
Inactivation of plasminogen ac ...... proteolysis with stromelysin-1
@nl
P2093
P2860
P356
P1476
Inactivation of plasminogen ac ...... is with stromelysin-1 (MMP-3).
@en
P2093
P2860
P304
37645-37650
P356
10.1074/JBC.M006475200
P407
P577
2000-12-01T00:00:00Z